A detailed history of Macquarie Group LTD transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Macquarie Group LTD holds 55,008 shares of ELAN stock, worth $769,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,008
Previous 75,327 26.97%
Holding current value
$769,011
Previous $1.09 Million 25.69%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $240,780 - $314,334
-20,319 Reduced 26.97%
55,008 $807,000
Q2 2024

Aug 09, 2024

BUY
$12.93 - $18.45 $973,978 - $1.39 Million
75,327 New
75,327 $1.09 Million
Q4 2022

Feb 21, 2023

BUY
$11.49 - $13.65 $80,958 - $96,177
7,046 Added 111.17%
13,384 $163,000
Q3 2022

Nov 14, 2022

SELL
$12.41 - $32.42 $248 - $648
-20 Reduced 0.31%
6,338 $79,000
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $54,571 - $74,003
-2,780 Reduced 30.42%
6,358 $125,000
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $39,587 - $46,574
1,606 Added 21.32%
9,138 $239,000
Q4 2021

Feb 11, 2022

SELL
$27.74 - $34.09 $17 Million - $20.9 Million
-614,115 Reduced 98.79%
7,532 $214,000
Q3 2021

Nov 12, 2021

BUY
$29.2 - $36.72 $52,151 - $65,581
1,786 Added 0.29%
621,647 $19.8 Million
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $17.2 Million - $21.6 Million
599,579 Added 2956.21%
619,861 $21.5 Million
Q1 2021

May 14, 2021

SELL
$27.85 - $34.49 $1.31 Million - $1.62 Million
-47,052 Reduced 69.88%
20,282 $597,000
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $1.31 Million - $1.6 Million
47,436 Added 238.4%
67,334 $2.07 Million
Q3 2020

Nov 13, 2020

BUY
$21.1 - $29.13 $101,406 - $139,998
4,806 Added 31.84%
19,898 $556,000
Q2 2020

Aug 11, 2020

SELL
$18.94 - $24.93 $53,562 - $70,502
-2,828 Reduced 15.78%
15,092 $324,000
Q1 2020

May 15, 2020

BUY
$16.68 - $32.25 $42,850 - $82,850
2,569 Added 16.74%
17,920 $401,000
Q4 2019

Feb 14, 2020

BUY
$25.29 - $29.45 $163,120 - $189,952
6,450 Added 72.46%
15,351 $452,000
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $289,172 - $394,593
-11,287 Reduced 55.91%
8,901 $237,000
Q2 2019

Aug 14, 2019

SELL
$31.11 - $34.79 $8.67 Million - $9.7 Million
-278,821 Reduced 93.25%
20,188 $683,000
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $5.37 Million - $6.08 Million
185,107 Added 162.51%
299,009 $9.59 Million
Q4 2018

Feb 15, 2019

BUY
$29.63 - $34.5 $411,916 - $479,619
13,902 Added 13.9%
113,902 $3.59 Million
Q3 2018

Nov 15, 2018

BUY
$34.1 - $36.19 $3.41 Million - $3.62 Million
100,000 New
100,000 $3.49 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.